Cargando…
Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials
The routine methods used to treat oncological diseases have a number of drawbacks, including non-specific action and severe side effects for patients. Furthermore, tumor diseases are associated with a suppression of the immune system that often leads to the inefficiency of standard treatment methods...
Autores principales: | Markov, O. V., Mironova, N. L., Vlassov, V. V., Zenkova, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662271/ https://www.ncbi.nlm.nih.gov/pubmed/29104773 |
Ejemplares similares
-
Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells
por: Markov, O. V., et al.
Publicado: (2016) -
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
por: Markov, Oleg V., et al.
Publicado: (2015) -
New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids
por: Patutina, O.A., et al.
Publicado: (2009) -
Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo
por: Mohamed, Islam Saber Ead, et al.
Publicado: (2022) -
Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model
por: Patutina, Olga A., et al.
Publicado: (2019)